4.6 Article

Hydrogen Sulfide Attenuates Ischemia-Reperfusion Injury in In Vitro and In Vivo Models of Intestine Free Tissue Transfer

Journal

PLASTIC AND RECONSTRUCTIVE SURGERY
Volume 125, Issue 6, Pages 1670-1678

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PRS.0b013e3181d4fdc5

Keywords

-

Categories

Ask authors/readers for more resources

Background: Ischemia-reperfusion injury is the propagation of injury following reintroduction of oxygen to previously ischemic tissue. The purpose of this study was to evaluate whether hydrogen sulfide provides protection against ischemia-reperfusion injury in enteric tissue. Methods: In vitro (enterocyte anoxia-normoxia) and in vivo (rat intestinal ischemia-reperfusion) models of ischemia-reperfusion injury were tested with or without the addition of hydrogen sulfide. Apoptotic index was determined in vitro, and gross appearance, histology, and villus height (a measure of mucosal integrity) were assessed in vivo. Statistical analysis was performed, and significance was defined as p < 0.05. Results: In vitro, cells treated with 10 mu M hydrogen sulfide after 1-hour anoxia experienced a significant decrease in apoptotic index compared with untreated control (0.5 +/- 0.3 percent versus 2.8 +/- 0.7 percent); after 3 hours of anoxia, cells treated with 1 mu M, 10 mu M, and 100 mu M hydrogen sulfide experienced significant decreases in apoptotic index versus untreated control (1.6 +/- 0.8 percent, 1.8 +/- 0.9 percent, and 2.8 +/- 0.7 percent versus 8.6 +/- 1.7 percent). In vivo, intestine treated with [10 mu M] or [100 mu M] hydrogen sulfide retained normal coloration and villus architecture after 1-hour ischemia; after 2 hours of ischemia, only intestine treated with [10 mu M] hydrogen sulfide appeared uninjured. After 1, 2, or 3 hours of ischemia, villus heights of intestine treated with [10 mu M] or [100 mu M] hydrogen sulfide were significantly higher than heights of non-hydrogen sulfide-treated villi. Conclusions: Hydrogen sulfide significantly attenuates ischemia-reperfusion injury in intestinal tissue in vitro and in vivo. These results have significant implications for enteric free tissue transfers and other gastrointestinal procedures in which ischemic intervals may be anticipated. (Plast. Reconstr. Surg. 125: 1670, 2010.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Surgery

Objective Comparison of Commercially Available Breast Implant Devices

Peter W. Henderson, David Nash, Marta Laskowski, Robert T. Grant

AESTHETIC PLASTIC SURGERY (2015)

Meeting Abstract Surgery

High-dose and low-dose brachytherapy may be performed safely with soft tissue coverage in salvage treatment of recurrent head and neck cancer

Peter W. Henderson, Bhupesh W. Parasahar, David M. Otterburn, David I. Kutler, Marc A. Cohen, Jason A. Spector

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)

Article Surgery

Basics of Lasers History, Physics, and Clinical Applications

Philipp Franck, Peter W. Henderson, Kenneth O. Rothaus

CLINICS IN PLASTIC SURGERY (2016)

Article Surgery

Successful Salvage of Late Anastomotic Thrombosis after Free Tissue Transfer

Peter W. Henderson, John G. Fernandez, Yeliz Cemal, Babak J. Mehrara, Andrea L. Pusic, Colleen M. McCarthy, Evan Matros, Peter G. Cordeiro, Joseph J. Disa

JOURNAL OF RECONSTRUCTIVE MICROSURGERY (2016)

Article Surgery

A Simple, Visually Oriented Communication System to Improve Postoperative Care Following Microvascular Free Tissue Transfer: Development, Results, and Implications

Peter W. Henderson, Wilmina Landford, Jason Gardenier, David M. Otterburn, Christine H. Rohde, Jason A. Spector

JOURNAL OF RECONSTRUCTIVE MICROSURGERY (2016)

Article Oncology

Neither high-dose nor low-dose brachytherapy increases flap morbidity in salvage treatment of recurrent head and neck cancer

Peter W. Henderson, David I. Kutler, Bhupesh Parashar, David M. Otterburn, Marc A. Cohen, Jason A. Spector

JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2016)

Article Orthopedics

Gluteus Maximus Advancement Flap Procedure for Reconstruction of Posterior Soft Tissue Deficiency in Revision Total Hip Arthroplasty

Benjamin F. Ricciardi, Peter W. Henderson, Alexander S. McLawhorn, Geoffrey H. Westrich, Mathias P. Bostrom, Lloyd B. Gayle

ORTHOPEDICS (2017)

Article Surgery

An Interdisciplinary Approach to the Prevention and Treatment of Groin Wound Complications After Lower Extremity Revascularization

Alyssa J. Reiffel, Peter W. Henderson, John K. Karwowski, Jason A. Spector

ANNALS OF VASCULAR SURGERY (2012)

Article Surgery

Use of Integra and Interval Brachytherapy in a 2-Stage Auricular Reconstruction After Excision of a Recurrent Keloid

Alyssa J. Reiffel, Allie M. Sohn, Peter W. Henderson, Natalia Fullerton, Jason A. Spector

JOURNAL OF CRANIOFACIAL SURGERY (2012)

Review Pediatrics

The surgical management of H-type rectovestibular fistula: a case report and brief review of the literature

Deirdre C. Kelleher, Peter W. Henderson, Arnold Coran, Nitsana A. Spigland

PEDIATRIC SURGERY INTERNATIONAL (2012)

Article Surgery

Mathematical Modeling and Frequency Gradient Analysis of Cellular and Vascular Invasion into Integra and Strattice: Toward Optimal Design of Tissue Regeneration Scaffolds

Alyssa J. Reiffel, Peter W. Henderson, David D. Krijgh, Daniel A. Belkin, Ying Zheng, Lawrence J. Bonassar, Abraham D. Stroock, Jason A. Spector

PLASTIC AND RECONSTRUCTIVE SURGERY (2012)

Article Cell Biology

Stromal-derived factor-1 delivered via hydrogel drug-delivery vehicle accelerates wound healing in vivo

Peter W. Henderson, Sunil P. Singh, David D. Krijgh, Masaya Yamamoto, Daniel C. Rafii, Josephine J. Sung, Shahin Rafii, Sina Y. Rabbany, Jason A. Spector

WOUND REPAIR AND REGENERATION (2011)

Article Surgery

Objective Comparison of FDA-Approved Breast Implant Products in the USA: 5-Year Update

Brianne Sullivan, Isabel Ryan, Peter W. Henderson

Summary: The study compared FDA-approved breast implant products from four companies and highlighted the market trends. Technological innovation and the recognition of BIA-ALCL have led to changes in breast implant products, helping surgeons make decisions on breast implant procedures.

AESTHETIC PLASTIC SURGERY (2021)

Letter Surgery

The first 25 years of DIEP flap breast reconstruction publications

Eric Bao, Annet Kuruvilla, Paul Shay, Taylor Ibelli, Peter Henderson

JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2022)

No Data Available